Avoiding apoptosis, the
naturally-occurring method by which the body rids itself of damaged
or unwanted cells, is one way that cancer and Stage 4 Cancer develops and progresses.
Apoptosis is triggered by
cell stress, DNA damage, developmental cues, and other signals from
within the body. Unfortunately, we commonly see cells in cancer
patients diverting this process. And in doing so their cancers are
able to survive, continue to develop, and even spread.
In short, the body
already has the equipment to rid itself of cancer; so the question is
“why are stage 4 cancer patients diverting apoptosis?”
Mutations
Bring About Stubborn and Resistant Stage 4 Cancers
Well, let’s consider
how apoptosis is triggered. There are two basic ways:
- From within the cell
- From outside the cell
For apoptosis to be
triggered from within, the process requires a protein, p53. Mutations
to the p53 protein gene can cause it to become inactive, thereby
preventing normal, healthy apoptosis. This type of mutation is seen
in almost 50 percent of all human cancer. Preventing such mutation is
a good step toward improving the overall results of treatment.
Stage
4 Cancers Can Dodge the Silver Bullet of Chemotherapy
Chemotherapy and
radiation cause DNA damage to cells by affecting their DNA. But,
because DNA mutation apoptosis triggers rely on p53, if the p53 is
itself mutated, apoptosis may never occur - saving cancer cells from
what would be imminent destruction.
There are many clinical
studies that show that customary protocols are seeing cancer
progressions and recurrences for just this reason. By employing
advanced nutritional treatments to prevent p53 oncogene mutation,
Envita works hard with patients to help their bodies enjoy normal and
healthy apoptosis.
Stage 4 Cancer
treatments fail repeatedly when treatment protocols are implemented,
which focus on symptoms and effects alone. In reality, these battles
are most often won by attacking the causes directly. Our chances of
success increase considerably when measures are taken to eliminate
deficiencies in nutrition, immunology, and the ability to eliminate
toxins.
Launching
an Attack on Cancer
It is possible to combine
treatments to trigger apoptosis from outside the cell, as well as
from inside the cell that do not require p53. In doing so, apoptosis
may be achieved in cancer cells that had previously been considered
“resistant” to traditional treatments. Envita works vigorously to
capitalize and even further this approach and its subsequent results.
Attacking apoptosis form outside the cell is essential for stage 4
cancer patients as chemotherapy has usually stopped working.
Envita provides its
patients with mitochondria dysfunction support with the necessary
nutrients and treatments to reestablish normal healthy function. More
than a decade of experience dealing with the most difficult stage 4
cancers has provided insight as to which treatments are most
successful in helping the body attack and eliminate cancer cells.
The
Better the Treatment – the Better the Result
Envita’s
Comprehensive Smart Oncology® (link to Envita cancer home page)
program integrates successful oncology combinations with our
aggressive natural therapies that affect apoptosis in cancer cells by
using tumor destruction methods that
actually rely solely on p53. Visit our PPMR process (link to Envita
home or PPMR home)or contact us speak to one of our patient-care
educators so that we can put an immediate plan in place for you.
No comments:
Post a Comment